INTERNATIONAL PATENT: JANSSEN PHARMACEUTICA NV FILES APPLICATION FOR "(PHTHALAZIN-3-YL)AMINE DERIVATIVES AS BFL-1 INHIBITORS FOR THE TREATMENT OF CANCER"

GENEVA, April 28 -- JANSSEN PHARMACEUTICA NV (Turnhoutseweg 302340 Beerse) filed a patent application (PCT/IB2025/060446) for "(PHTHALAZIN-3-YL)AMINE DERIVATIVES AS BFL-1 INHIBITORS FOR THE TREATMENT OF CANCER" on Oct 14, 2025. With publication no. WO/2026/083265, the details related to the patent application was published on Apr 23, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SVEC, Riley L. (1400 McKean RoadSpring HousePennsylvania 19477), SODANO, Taylor M. (1400 McKean RoadSpring HousePennsylvania 19477), BRYAN, Marian C. (1400 McKean RoadSpring HousePennsylvania 19477), ROBERTSON, Jam...